摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S)-6,7-二甲氧基-1,2-二甲基-3,4-二氢-1H-异喹啉-5-醇 | 32829-58-6

中文名称
(1S)-6,7-二甲氧基-1,2-二甲基-3,4-二氢-1H-异喹啉-5-醇
中文别名
——
英文名称
Gigantin
英文别名
Gigantine;(1S)-6,7-dimethoxy-1,2-dimethyl-3,4-dihydro-1H-isoquinolin-5-ol
(1S)-6,7-二甲氧基-1,2-二甲基-3,4-二氢-1H-异喹啉-5-醇化学式
CAS
32829-58-6
化学式
C13H19NO3
mdl
——
分子量
237.299
InChiKey
HRJQUAXWKYISJC-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    151-152°
  • 比旋光度:
    D25 +27.1° (c = 2 in chloroform)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    41.9
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933499090

文献信息

  • RIBOTOXIN MOLECULES DERIVED FROM SARCIN AND OTHER RELATED FUNGAL RIBOTOXINS
    申请人:Research Corporation Technologies, Inc
    公开号:EP2971038A1
    公开(公告)日:2016-01-20
  • COMPOSITIONS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
    申请人:Borody, Thomas Julius
    公开号:EP2991649B1
    公开(公告)日:2020-06-03
  • METHODS OF SCREENING, SELECTING, AND IDENTIFYING CYTOTOXIC RECOMBINANT POLYPEPTIDES BASED ON AN INTERIM DIMINUTION OF RIBOTOXICITY
    申请人:Molecular Templates, Inc.
    公开号:EP3102245B1
    公开(公告)日:2021-09-08
  • [EN] RIBOTOXIN MOLECULES DERIVED FROM SARCIN AND OTHER RELATED FUNGAL RIBOTOXINS<br/>[FR] MOLÉCULES DE RIBOTOXINES DÉRIVÉES DE SARCINE ET AUTRES RIBOTOXINES FONGIQUES ASSOCIÉES
    申请人:RES CORP TECHNOLOGIES INC
    公开号:WO2014158770A1
    公开(公告)日:2014-10-02
    The present application relates to modified T cell epitopes derived from fungal ribotoxins, including a-sarcin, clavin, gigantin, mitogillin, and restrictocin, as well as modified ribotoxin molecules comprising one or more of the modified epitopes. The modified ribotoxin molecules inhibit protein synthesis, like the wild type ribotoxins, but exhibit reduced immunogenicity as compared to the corresponding wild type ribotoxin. Another aspect relates to a fusion protein which comprises a modified ribotoxin fused or conjugated or otherwise linked to a targeting molecule that is effective for binding a target of interest. Another aspect relates to the use of the modified ribotoxin or fusion protein for treating or managing a disease or condition.
查看更多